Clostridioides difficile in Children - 28/10/25
, Thomas J. Sandora, MD, MPH c, d, Preeti Mehrotra, MD, MPH e, fRésumé |
After a significant increase in pediatric Clostridioides difficile infection (CDI) in the United States over the past 2 decades, incidence has declined over the past 5 y. Community-associated CDI incidence is 3 times higher than healthcare facility-associated CDI in children, but sources of community acquisition are poorly defined. Diagnosis of CDI is challenging because of high frequency of colonization in infants and some groups of older children. Recent data suggest that vancomycin should be considered a first-line treatment for CDI in children and that fidaxomicin and fecal microbiota transplantation are safe and effective therapies for recurrent CDI.
Le texte complet de cet article est disponible en PDF.Keywords : Clostridioides difficile, Children, Pediatric, Infants, Colonization, Epidemiology, Diagnosis, Treatment
Plan
Vol 39 - N° 4
P. 709-725 - décembre 2025 Retour au numéro
Article précédent
- Infection Prevention Approaches for Clostridioides difficile
- Jesse Vance, Nicholas A. Turner
- Making Sense of Differing Guidelines for Clostridioides difficile Infection
- Kanika Sehgal, Paul Feuerstadt, Mark H. Wilcox
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?